Steffen Leusmann studied pharmacy at Saarland University and received his license to practise pharmacy in 2021. After his master thesis on pathoblockers of P. aeruginosa in the group of Dr. Alexander Titz, he started his PhD studies in the same group in 2022. His research focusses on synthesis and optimisation of glycomimetic biofilm inhibitors.